OPRX - OptimizeRx Non-GAAP EPS of -$0.01 beats by $0.01 revenue of $13.82M misses by $0.99M
2023-08-14 16:02:21 ET
More on OptimizeRx
- OptimizeRx Aims For Growth After Swoon
- OptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19%
- Hilton Grand Vacations rallies after S&P MidCap 400 Index callup
- OptimizeRx stock sinks 26% on Q2 miss, while FY22 outlook cut on life sciences sector woes
- OptimizeRx to acquire specialty drug prescription platform Evincemed
- Seeking Alpha’s Quant Rating on OptimizeRx
- Earnings data for OptimizeRx
For further details see:
OptimizeRx Non-GAAP EPS of -$0.01 beats by $0.01, revenue of $13.82M misses by $0.99M